NEW YORK (Reuters Health) – Rather than a 24-hour urine collection to measure proteinuria, a 12-hour urine protein determination and the protein:creatinine ratio can be used for evaluating…
NEW YORK (Reuters Health) – When ventilator-associated pneumonia (VAP) is suspected, the absence of Gram staining on a respiratory specimen reliably rules out the diagnosis. On the other…
NEW YORK (Reuters Health) – Rates of maternal morbidity among women with gestational hypertension are lowest when labor is induced at 38 weeks while neonatal morbidity/mortality rates are…
NEW YORK (Reuters Health) – Sialendoscopy is safe and effective for the treatment of obstructive diseases of the salivary glands in adults, according results of a systematic review…
NEW YORK (Reuters Health) – In clinical practice, XIENCE V everolimus-eluting coronary stent is associated with low event rates at one year, according to a large post-marketing study.…
NEW YORK (Reuters Health) – As a treatment for primary dysmenorrhea, continuous oral contraceptives (OCs) outperform cyclic oral contraceptives, but this advantage is lost after 6 months, according…
NEW YORK (Reuters Health) – Patients with inflammatory joint disease (IJD), including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, respond as well to statin therapy as those without…
NEW YORK (Reuters Health) – For most women, a limited course of antibiotic treatment is sufficient for treating chorioamnionitis, according to a report in the June Obstetrics &…
NEW YORK (Reuters Health) – Smoke from organic matter used as fuel – known as biomass smoke — worsens lung function in young adults, researchers from UK report…
NEW YORK (Reuters Health) – Neurally adjusted ventilatory assist (NAVA) reduces patient-ventilator asynchrony without compromising gas exchange in patients with acute respiratory failure undergoing noninvasive ventilation (NIV), researchers…
NEW YORK (Reuters Health) – The interferon-gamma release assay (IGRA) is more specific, at least as sensitive, and may better predict disease progression than the tuberculin skin test…
NEW YORK (Reuters Health) – In a phase three study of elderly patients with newly diagnosed acute myeloid leukemia (AML), decitabine achieved a higher response rate, with a…
